OrganoTherapeutics

Description

OrganoTherapeutics creates human iPSC-derived midbrain organoids, assembloids, and patient-specific Parkinson’s cell models, then provides experiments, data analysis, and interpretation to support preclinical drug research for brain disorders.

OrganoTherapeutics is located in the Luxembourg ecosystem.

Related

• bit.biobit.bio provides deterministically programmed human iPSC-derived cells and CRISPR screening services for research and drug discovery,…
• InSpheroInSphero provides human-tissue 3D in vitro cell-culture models, spheroid and organoid tools, and automation-compatible plates that support…
• BioArcticBioArctic develops therapeutics and related technologies for neurodegenerative disorders, focusing on disease-modifying treatments and…
• Anacalypsis TherapeuticsAnacalypsis Therapeutics creates precision gene- and pathway-based therapeutic strategies, biomarkers, and genetically linked targets to…
• CARTHERACARTHERA develops SonoCloud, an implanted ultrasound device that emits low-intensity pulsed ultrasound to transiently open the blood–brain…
• Prevision MedicinePrevision Medicine tests living cancer and healthy cells from a patient biopsy against 100+ drugs and combinations using a patented ex vivo…
• ceregateceregate provides a hardware-agnostic computer–brain interface platform that enables new communication channels with the brain to restore…
• GenomizeGenomize provides the SEQ Platform, which performs comprehensive NGS data analysis, builds real-time genotype/phenotype databases, and…
• Newronika SPANewronika SPA builds an adaptive deep brain stimulation system that senses neural signals and adjusts therapy in real time; used by…